| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 18 | 2010 | 34 | 0.770 |
Why?
|
| Interleukin-17 | 5 | 2011 | 110 | 0.720 |
Why?
|
| T-Lymphocytes | 12 | 2011 | 1310 | 0.590 |
Why?
|
| CD28 Antigens | 4 | 2011 | 94 | 0.590 |
Why?
|
| Thymus Gland | 11 | 2002 | 206 | 0.530 |
Why?
|
| Lymphocyte Activation | 11 | 2011 | 810 | 0.510 |
Why?
|
| Receptors, Immunologic | 3 | 2011 | 142 | 0.410 |
Why?
|
| Tenodesis | 1 | 2013 | 6 | 0.400 |
Why?
|
| Protein-Tyrosine Kinases | 14 | 1999 | 303 | 0.400 |
Why?
|
| Signal Transduction | 15 | 2011 | 3581 | 0.400 |
Why?
|
| Receptors, Interleukin-17 | 2 | 2011 | 10 | 0.360 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2009 | 2 | 0.310 |
Why?
|
| Antigens, CD | 5 | 2009 | 480 | 0.310 |
Why?
|
| CD4 Antigens | 6 | 2001 | 82 | 0.300 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 75 | 0.300 |
Why?
|
| Ubiquitin | 1 | 2009 | 95 | 0.290 |
Why?
|
| CD8 Antigens | 6 | 2001 | 84 | 0.290 |
Why?
|
| Ligands | 2 | 2009 | 478 | 0.280 |
Why?
|
| Killer Cells, Natural | 2 | 2009 | 292 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2004 | 684 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2004 | 431 | 0.260 |
Why?
|
| Mice | 32 | 2011 | 12536 | 0.260 |
Why?
|
| Shoulder Joint | 4 | 2013 | 100 | 0.250 |
Why?
|
| Interleukins | 4 | 2011 | 134 | 0.230 |
Why?
|
| Milk Proteins | 3 | 2002 | 24 | 0.230 |
Why?
|
| Interleukin-7 | 3 | 2002 | 47 | 0.230 |
Why?
|
| Mice, Transgenic | 16 | 2011 | 1645 | 0.220 |
Why?
|
| Molecular Sequence Data | 14 | 2011 | 3040 | 0.210 |
Why?
|
| Animals | 36 | 2011 | 28888 | 0.200 |
Why?
|
| Patient Positioning | 2 | 2014 | 65 | 0.200 |
Why?
|
| Cytokines | 4 | 2010 | 871 | 0.190 |
Why?
|
| Cell Differentiation | 8 | 2011 | 1662 | 0.180 |
Why?
|
| Arthroscopy | 3 | 2013 | 106 | 0.180 |
Why?
|
| Growth Inhibitors | 2 | 2011 | 41 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 1124 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 12 | 2011 | 3490 | 0.160 |
Why?
|
| B-Lymphocyte Subsets | 2 | 1999 | 42 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2004 | 290 | 0.150 |
Why?
|
| Biomechanical Phenomena | 2 | 2013 | 506 | 0.150 |
Why?
|
| Rotator Cuff | 2 | 2010 | 51 | 0.150 |
Why?
|
| Amino Acid Sequence | 12 | 2011 | 2090 | 0.150 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 164 | 0.140 |
Why?
|
| Cells, Cultured | 7 | 2011 | 2929 | 0.140 |
Why?
|
| Calcium | 3 | 2004 | 1205 | 0.140 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 2061 | 0.130 |
Why?
|
| Mice, Knockout | 9 | 2011 | 2161 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 483 | 0.120 |
Why?
|
| Anesthesia, General | 2 | 2014 | 127 | 0.110 |
Why?
|
| Cadaver | 2 | 2013 | 204 | 0.110 |
Why?
|
| Cell Line | 7 | 2011 | 2536 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2014 | 253 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2002 | 446 | 0.100 |
Why?
|
| GATA3 Transcription Factor | 2 | 2010 | 52 | 0.100 |
Why?
|
| Anesthesia, Conduction | 1 | 2013 | 24 | 0.100 |
Why?
|
| Hematopoiesis | 2 | 1993 | 182 | 0.100 |
Why?
|
| Awards and Prizes | 1 | 2013 | 37 | 0.100 |
Why?
|
| Rotator Cuff Injuries | 2 | 2010 | 52 | 0.090 |
Why?
|
| Oximetry | 1 | 2013 | 90 | 0.090 |
Why?
|
| T-Box Domain Proteins | 2 | 2010 | 128 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2013 | 277 | 0.090 |
Why?
|
| Receptors, Interleukin-7 | 3 | 2002 | 30 | 0.090 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2011 | 25 | 0.090 |
Why?
|
| Lymphocytes | 4 | 2003 | 465 | 0.090 |
Why?
|
| Immunity, Mucosal | 1 | 2011 | 72 | 0.090 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2010 | 6 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2011 | 126 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 423 | 0.080 |
Why?
|
| Suture Anchors | 1 | 2010 | 7 | 0.080 |
Why?
|
| Humans | 21 | 2014 | 95798 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2009 | 288 | 0.080 |
Why?
|
| Cricetinae | 2 | 2011 | 542 | 0.080 |
Why?
|
| Tendons | 1 | 2010 | 49 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2002 | 1267 | 0.080 |
Why?
|
| Protein Transport | 2 | 2009 | 439 | 0.080 |
Why?
|
| Enzyme Activation | 6 | 2004 | 692 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2010 | 166 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2010 | 171 | 0.080 |
Why?
|
| B7 Antigens | 1 | 2009 | 5 | 0.080 |
Why?
|
| Antibodies, Bispecific | 1 | 2009 | 37 | 0.080 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 1993 | 16 | 0.080 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2014 | 41 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2010 | 105 | 0.080 |
Why?
|
| K562 Cells | 1 | 2009 | 49 | 0.080 |
Why?
|
| Interleukin-23 | 1 | 2009 | 60 | 0.080 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2009 | 26 | 0.080 |
Why?
|
| Immunologic Memory | 1 | 2010 | 188 | 0.080 |
Why?
|
| Bursa, Synovial | 1 | 2009 | 3 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2009 | 104 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2010 | 151 | 0.070 |
Why?
|
| Tendon Injuries | 1 | 2009 | 39 | 0.070 |
Why?
|
| Transfection | 4 | 2007 | 908 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 257 | 0.070 |
Why?
|
| Carbon Dioxide | 2 | 2014 | 212 | 0.070 |
Why?
|
| Protein Engineering | 1 | 2009 | 150 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2009 | 469 | 0.070 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 156 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 2 | 2013 | 116 | 0.070 |
Why?
|
| Protein Binding | 4 | 2007 | 1560 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 350 | 0.070 |
Why?
|
| Interleukin-2 | 3 | 2011 | 246 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2007 | 147 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 564 | 0.070 |
Why?
|
| Receptors, Cytokine | 4 | 2011 | 30 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2009 | 618 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 5 | 1996 | 96 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 161 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 825 | 0.060 |
Why?
|
| Male | 12 | 2014 | 45685 | 0.060 |
Why?
|
| Tyrosine | 5 | 2002 | 132 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2011 | 541 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2007 | 220 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2010 | 488 | 0.060 |
Why?
|
| Species Specificity | 1 | 2007 | 707 | 0.060 |
Why?
|
| Flow Cytometry | 6 | 2010 | 726 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2009 | 464 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 3 | 2002 | 45 | 0.060 |
Why?
|
| Apoptosis | 2 | 2004 | 1756 | 0.060 |
Why?
|
| src-Family Kinases | 3 | 2004 | 70 | 0.050 |
Why?
|
| Rats | 1 | 2011 | 4154 | 0.050 |
Why?
|
| Transgenes | 2 | 2004 | 186 | 0.050 |
Why?
|
| Dermatitis | 1 | 2004 | 35 | 0.050 |
Why?
|
| Leukemia, T-Cell | 1 | 2003 | 17 | 0.050 |
Why?
|
| Middle Aged | 6 | 2014 | 28206 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 80 | 0.050 |
Why?
|
| Stroke | 1 | 2013 | 1087 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 2777 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 162 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1809 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1993 | 69 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 509 | 0.050 |
Why?
|
| Aged | 4 | 2014 | 20848 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 224 | 0.050 |
Why?
|
| Stromal Cells | 2 | 2002 | 152 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 278 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2002 | 265 | 0.040 |
Why?
|
| Female | 9 | 2014 | 49868 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 760 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2011 | 40 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 4 | 2004 | 22 | 0.040 |
Why?
|
| Phosphorylation | 3 | 1999 | 1156 | 0.040 |
Why?
|
| Interleukin-4 | 2 | 2010 | 135 | 0.040 |
Why?
|
| src Homology Domains | 1 | 1999 | 45 | 0.040 |
Why?
|
| Proline | 1 | 1999 | 56 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 930 | 0.040 |
Why?
|
| Janus Kinase 3 | 1 | 1999 | 9 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 1999 | 15 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 4 | 2009 | 1425 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 1 | 1999 | 39 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2010 | 261 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 59 | 0.040 |
Why?
|
| Base Sequence | 5 | 1994 | 2342 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 1999 | 164 | 0.040 |
Why?
|
| Interferon-gamma | 2 | 2010 | 462 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1998 | 65 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 98 | 0.030 |
Why?
|
| Fetus | 1 | 1999 | 239 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1991 | 463 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 1999 | 270 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2003 | 516 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1996 | 33 | 0.030 |
Why?
|
| CD3 Complex | 3 | 2004 | 136 | 0.030 |
Why?
|
| Gene Expression | 3 | 1994 | 1319 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2014 | 36 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 98 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2014 | 59 | 0.030 |
Why?
|
| Shoulder | 1 | 2014 | 43 | 0.030 |
Why?
|
| Liver | 1 | 1999 | 1231 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 68 | 0.030 |
Why?
|
| Kinetics | 2 | 2009 | 1561 | 0.030 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1993 | 9 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1993 | 113 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 1993 | 115 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 126 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2004 | 2089 | 0.020 |
Why?
|
| Mitosis | 1 | 1993 | 152 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1993 | 111 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 2039 | 0.020 |
Why?
|
| Citrobacter rodentium | 1 | 2011 | 14 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 12 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2011 | 50 | 0.020 |
Why?
|
| Heart Rate | 1 | 2014 | 518 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2011 | 23 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2004 | 740 | 0.020 |
Why?
|
| fas Receptor | 2 | 2004 | 76 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 1046 | 0.020 |
Why?
|
| Thymoma | 1 | 1991 | 33 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2010 | 4 | 0.020 |
Why?
|
| Oncogenes | 1 | 1991 | 99 | 0.020 |
Why?
|
| L-Selectin | 1 | 2010 | 17 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 1991 | 47 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 132 | 0.020 |
Why?
|
| Shoulder Dislocation | 1 | 2010 | 18 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 2000 | 648 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 65 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2014 | 775 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 205 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2013 | 4664 | 0.020 |
Why?
|
| Catheters | 1 | 2010 | 90 | 0.020 |
Why?
|
| Alleles | 1 | 1993 | 1157 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 291 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 926 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2010 | 181 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2010 | 116 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2010 | 88 | 0.020 |
Why?
|
| Single-Chain Antibodies | 1 | 2009 | 21 | 0.020 |
Why?
|
| Half-Life | 1 | 2009 | 99 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2010 | 89 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 38 | 0.020 |
Why?
|
| Time Factors | 1 | 1999 | 5561 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2002 | 336 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 380 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 52 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 106 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 180 | 0.020 |
Why?
|
| Sprains and Strains | 1 | 2009 | 12 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 706 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 526 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 1008 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2010 | 238 | 0.020 |
Why?
|
| Hypoxia | 1 | 2014 | 681 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 128 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 86 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1714 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 542 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 364 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2010 | 417 | 0.020 |
Why?
|
| Proteins | 1 | 1993 | 816 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2009 | 627 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1987 | 144 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1827 | 0.020 |
Why?
|
| Cell Division | 2 | 2002 | 701 | 0.020 |
Why?
|
| Peptides | 2 | 1999 | 671 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 3904 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 995 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1991 | 1346 | 0.010 |
Why?
|
| Mutation | 3 | 1998 | 4374 | 0.010 |
Why?
|
| Inflammation | 1 | 2011 | 1063 | 0.010 |
Why?
|
| Lectins, C-Type | 2 | 1996 | 89 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1753 | 0.010 |
Why?
|
| Spleen | 2 | 1998 | 420 | 0.010 |
Why?
|
| Receptors, Oncostatin M | 1 | 2004 | 1 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 25 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2004 | 39 | 0.010 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2004 | 37 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 50 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Cyclin D3 | 1 | 2003 | 21 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 67 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 2003 | 1275 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2004 | 110 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2003 | 85 | 0.010 |
Why?
|
| DNA | 1 | 1989 | 1327 | 0.010 |
Why?
|
| Solubility | 1 | 2004 | 190 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2004 | 87 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 358 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2003 | 136 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2014 | 2592 | 0.010 |
Why?
|
| Antigens | 1 | 2004 | 231 | 0.010 |
Why?
|
| Immunologic Capping | 1 | 2002 | 10 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2002 | 11 | 0.010 |
Why?
|
| Protein Kinase C-theta | 1 | 2002 | 16 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2004 | 166 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2003 | 318 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 286 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 2479 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2003 | 263 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2003 | 415 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 1996 | 996 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2003 | 562 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 477 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2002 | 145 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 2474 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 282 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 453 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 701 | 0.010 |
Why?
|
| Phosphotyrosine | 2 | 1991 | 31 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 252 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 465 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 750 | 0.010 |
Why?
|
| Oncostatin M | 1 | 1999 | 1 | 0.010 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 1999 | 20 | 0.010 |
Why?
|
| United States | 1 | 2013 | 7764 | 0.010 |
Why?
|
| Genes, fos | 1 | 1999 | 24 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 1999 | 84 | 0.010 |
Why?
|
| Alanine | 1 | 1999 | 85 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 687 | 0.010 |
Why?
|
| Retroviridae | 1 | 1999 | 76 | 0.010 |
Why?
|
| Ionomycin | 1 | 1998 | 21 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 1805 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1998 | 108 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 85 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1535 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 1998 | 165 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 113 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 301 | 0.010 |
Why?
|
| Lung | 1 | 2004 | 1380 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 28578 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1996 | 18 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 212 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1994 | 65 | 0.010 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1993 | 16 | 0.010 |
Why?
|
| Genes | 1 | 1994 | 307 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1993 | 46 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1994 | 620 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1992 | 232 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 39 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1991 | 329 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1991 | 179 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1994 | 1080 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1991 | 446 | 0.000 |
Why?
|
| Moloney murine leukemia virus | 1 | 1989 | 5 | 0.000 |
Why?
|
| Cysteine | 1 | 1990 | 146 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1990 | 216 | 0.000 |
Why?
|
| Binding Sites | 1 | 1991 | 1167 | 0.000 |
Why?
|
| Lysine | 1 | 1989 | 190 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1989 | 777 | 0.000 |
Why?
|
| Melanoma | 1 | 1987 | 495 | 0.000 |
Why?
|
| Phenotype | 1 | 1989 | 2575 | 0.000 |
Why?
|